Alessandra Cesano - Feb 8, 2024 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 06:15 PM
Previous filing
Jan 4, 2024
Next filing
Mar 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +74K $0.00 74K Feb 8, 2024 Common Stock 74K $11.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in 36 equal monthly installments starting one month after grant date of February 8, 2024.